TY - JOUR
T1 - Altered cerebral response during cognitive control
T2 - A potential indicator of genetic liability for schizophrenia
AU - Sambataro, Fabio
AU - Mattay, Venkata S.
AU - Thurin, Kristina
AU - Safrin, Martin
AU - Rasetti, Roberta
AU - Blasi, Giuseppe
AU - Callicott, Joseph H.
AU - Weinberger, Daniel R.
N1 - Funding Information:
This research was supported by the Intramural Research Program of the National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.
PY - 2013/4
Y1 - 2013/4
N2 - Aberrant activity in brain regions underlying various aspects of executive cognition has been reported in patients with schizophrenia and in their healthy relatives, suggesting an association with genetic liability. The aim of this study was to investigate brain responses to selective aspects of cognitive control in unaffected siblings who are at increased genetic risk of schizophrenia. Altogether, 65 non-affected siblings, 70 patients with schizophrenia spectrum disorders, anD235 normal controls participated in this study. Blood-oxygen-Ievel-dependent functional magnetic resonance imaging was conducted while participants performed a cognitive control task ('flanker task') to identify brain activity and connectivity associated with response inhibition and conflict monitoring, and suppression. Behaviorally, similar to patients with schizophrenia, siblings were less accurate when inhibiting prepotent responses relative to normal controls. During response inhibition, again similar to patients with schizophrenia, siblings showed decreased activity in the anterior cingulate (ACC), along with increased functional coupling with the dorsolateral prefrontal cortex (PFC) when compared to normal controls. Our findings show altered ACC activity and PFC connectivity in unaffected siblings and patients with schizophrenia during response inhibition. These results suggest that such changes in the neural activity underlying aspects of cognitive control may represent a potential intermediate phenotype for the investigation of the genetic basis of schizophrenia.
AB - Aberrant activity in brain regions underlying various aspects of executive cognition has been reported in patients with schizophrenia and in their healthy relatives, suggesting an association with genetic liability. The aim of this study was to investigate brain responses to selective aspects of cognitive control in unaffected siblings who are at increased genetic risk of schizophrenia. Altogether, 65 non-affected siblings, 70 patients with schizophrenia spectrum disorders, anD235 normal controls participated in this study. Blood-oxygen-Ievel-dependent functional magnetic resonance imaging was conducted while participants performed a cognitive control task ('flanker task') to identify brain activity and connectivity associated with response inhibition and conflict monitoring, and suppression. Behaviorally, similar to patients with schizophrenia, siblings were less accurate when inhibiting prepotent responses relative to normal controls. During response inhibition, again similar to patients with schizophrenia, siblings showed decreased activity in the anterior cingulate (ACC), along with increased functional coupling with the dorsolateral prefrontal cortex (PFC) when compared to normal controls. Our findings show altered ACC activity and PFC connectivity in unaffected siblings and patients with schizophrenia during response inhibition. These results suggest that such changes in the neural activity underlying aspects of cognitive control may represent a potential intermediate phenotype for the investigation of the genetic basis of schizophrenia.
KW - anterior cingulate
KW - functional magnetic resonance imaging
KW - heritability
KW - intermediate phenotype
KW - response inhibition
UR - http://www.scopus.com/inward/record.url?scp=84875227712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875227712&partnerID=8YFLogxK
U2 - 10.1038/npp.2012.250
DO - 10.1038/npp.2012.250
M3 - Article
C2 - 23299932
AN - SCOPUS:84875227712
SN - 0893-133X
VL - 38
SP - 846
EP - 853
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 5
ER -